Orthopaedic journal of sports medicine · 2026
Return to Sport and Performance After Treatment of Osteochondral Lesions of the Ankle in Elite Athletes: A Retrospective Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ter Laak Bolk Carlijn S, Hollander Julian J, Geurts Elze J, Ramsodit Kishan R, Rikken Quinten G H, Dahmen Jari, Stufkens Sjoerd A S, Kerkhoffs Gino M M J
Аннотация
BACKGROUND: Osteochondral lesions of the ankle (OLA) often occur in athletes, necessitating a focus on sport outcomes such as return to sports (RTS) and return to performance (RTP). Only a few studies have evaluated sports outcomes after treatment of an osteochondral lesion in the athletic population, let alone in an elite athlete population.
PURPOSE: To assess RTS and RTP rates and times after treatment of OLA in elite athletes.
STUDY DESIGN: Case series; Level of evidence, 4.
METHODS: All elite athletes treated for an OLA were selected from a cross-sectional database consisting of consecutive patients with cartilage injuries of the ankle until August 2022. Outcomes included RTS outcomes, patient-reported outcomes, and a quantitative assessment regarding mental health.
RESULTS: A total of 25 patients, with a median age of 22 years (interquartile range [IQR], 19-25 years), were included, with a median follow-up time of 48 months (IQR, 35-71 months). Six patients (24%) underwent nonoperative treatment, and 19 patients (76%) underwent operative treatment. Nonoperative treatment yielded RTS rates of 83% at any level, 67% at the preinjury level, and 67% for RTP. For operative treatment, these rates were 100%, 74%, and 63%, respectively. The median time to return to preinjury level was 7.5 months overall.
CONCLUSION: The different treatment options for OLAs allowed for adequate RTS and RTP outcomes. Overall, an RTS rate of 96% at any level, a return to the preinjury level of 72%, and an RTP of 64% were found. These sport-specific outcomes can inform athletes about their expected outcomes after different treatments for OLAs.
PURPOSE: To assess RTS and RTP rates and times after treatment of OLA in elite athletes.
STUDY DESIGN: Case series; Level of evidence, 4.
METHODS: All elite athletes treated for an OLA were selected from a cross-sectional database consisting of consecutive patients with cartilage injuries of the ankle until August 2022. Outcomes included RTS outcomes, patient-reported outcomes, and a quantitative assessment regarding mental health.
RESULTS: A total of 25 patients, with a median age of 22 years (interquartile range [IQR], 19-25 years), were included, with a median follow-up time of 48 months (IQR, 35-71 months). Six patients (24%) underwent nonoperative treatment, and 19 patients (76%) underwent operative treatment. Nonoperative treatment yielded RTS rates of 83% at any level, 67% at the preinjury level, and 67% for RTP. For operative treatment, these rates were 100%, 74%, and 63%, respectively. The median time to return to preinjury level was 7.5 months overall.
CONCLUSION: The different treatment options for OLAs allowed for adequate RTS and RTP outcomes. Overall, an RTS rate of 96% at any level, a return to the preinjury level of 72%, and an RTP of 64% were found. These sport-specific outcomes can inform athletes about their expected outcomes after different treatments for OLAs.